Letter to the Editor: Very low-dose antithymocyte globulin (thymoglobulin) is effective for steroid-refractory acute graft-versus-host disease involving the skin or gut after allogeneic hematopoietic stem cell transplantation
Gespeichert in:
Veröffentlicht in: | International journal of hematology 2022-03, Vol.115 (3), p.449-451 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 451 |
---|---|
container_issue | 3 |
container_start_page | 449 |
container_title | International journal of hematology |
container_volume | 115 |
creator | Yamada, Yuta Konishi, Tatsuya Nagata, Akihito Toya, Takashi Najima, Yuho Kobayashi, Takeshi Ohashi, Kazuteru Doki, Noriko |
description | |
doi_str_mv | 10.1007/s12185-021-03234-3 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2622479941</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2622479941</sourcerecordid><originalsourceid>FETCH-LOGICAL-c399t-6eddeeeb62ea759e8b31948dd33735acb3c3e9775dae16fc55bc9b9068eb0ef43</originalsourceid><addsrcrecordid>eNp9kk-P1CAYxonRuOPqF_BgSLysBxRKKcWb2ax_kkm8qNeGwtsOKy0j0DH9uH4TmZldTTx4IsDz_p4n8CD0nNHXjFL5JrGKtYLQihHKK14T_gBtWNsIwqWsH6INVZUgQjJ6gZ6kdEspk7SWj9EFF7RpWko36NcWcoaIc8B5B_jGuhziW_wN4op9-ElsSID1nF3erVMwawY8-tAv3s346nR2v32FXcIwDGCyOwAeQsSpkIOzJMIQtSngFWuzHBFRD5kcIKYlkV1IGVuXQBcrNx-CP7h5PMVJ34tNAY1LxmWi5NTehxFmcAbvYNI57IODXHbFa8IGvMc56jntfQmtswvzU_Ro0D7Bs7v1En19f_Pl-iPZfv7w6frdlhiuVCYNWAsAfVOBlkJB23Om6tZaziUX2vTccFBSCquBNYMRojeqV7Rpoacw1PwSXZ25-xh-LJByN7l0DKRnCEvqqqaqaqlUzYr05T_S27DEuaQrKs6FFLU6AquzysSQUnnDbh_dpOPaMdodC9CdC9CVAnSnAnS8DL24Qy_9BPbPyP2PFwE_C1K5mkeIf73_g_0NO4fDRw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2633575494</pqid></control><display><type>article</type><title>Letter to the Editor: Very low-dose antithymocyte globulin (thymoglobulin) is effective for steroid-refractory acute graft-versus-host disease involving the skin or gut after allogeneic hematopoietic stem cell transplantation</title><source>MEDLINE</source><source>SpringerLink Journals</source><creator>Yamada, Yuta ; Konishi, Tatsuya ; Nagata, Akihito ; Toya, Takashi ; Najima, Yuho ; Kobayashi, Takeshi ; Ohashi, Kazuteru ; Doki, Noriko</creator><creatorcontrib>Yamada, Yuta ; Konishi, Tatsuya ; Nagata, Akihito ; Toya, Takashi ; Najima, Yuho ; Kobayashi, Takeshi ; Ohashi, Kazuteru ; Doki, Noriko</creatorcontrib><identifier>ISSN: 0925-5710</identifier><identifier>EISSN: 1865-3774</identifier><identifier>DOI: 10.1007/s12185-021-03234-3</identifier><identifier>PMID: 35066800</identifier><language>eng</language><publisher>Singapore: Springer Singapore</publisher><subject>Acute Disease ; Antilymphocyte Serum ; Globulins ; Graft vs Host Disease - drug therapy ; Graft vs Host Disease - etiology ; Graft vs Host Disease - prevention & control ; Graft-versus-host reaction ; Hematology ; Hematopoietic Stem Cell Transplantation ; Hematopoietic stem cells ; Humans ; Letter to the Editor ; Medicine ; Medicine & Public Health ; Oncology ; Skin diseases ; Stem cell transplantation ; Stem cells ; Steroids ; Thymocytes ; Thymoglobulin ; Transplantation</subject><ispartof>International journal of hematology, 2022-03, Vol.115 (3), p.449-451</ispartof><rights>Japanese Society of Hematology 2022</rights><rights>Japanese Society of Hematology 2022.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c399t-6eddeeeb62ea759e8b31948dd33735acb3c3e9775dae16fc55bc9b9068eb0ef43</citedby><cites>FETCH-LOGICAL-c399t-6eddeeeb62ea759e8b31948dd33735acb3c3e9775dae16fc55bc9b9068eb0ef43</cites><orcidid>0000-0002-8661-3179</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s12185-021-03234-3$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s12185-021-03234-3$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35066800$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yamada, Yuta</creatorcontrib><creatorcontrib>Konishi, Tatsuya</creatorcontrib><creatorcontrib>Nagata, Akihito</creatorcontrib><creatorcontrib>Toya, Takashi</creatorcontrib><creatorcontrib>Najima, Yuho</creatorcontrib><creatorcontrib>Kobayashi, Takeshi</creatorcontrib><creatorcontrib>Ohashi, Kazuteru</creatorcontrib><creatorcontrib>Doki, Noriko</creatorcontrib><title>Letter to the Editor: Very low-dose antithymocyte globulin (thymoglobulin) is effective for steroid-refractory acute graft-versus-host disease involving the skin or gut after allogeneic hematopoietic stem cell transplantation</title><title>International journal of hematology</title><addtitle>Int J Hematol</addtitle><addtitle>Int J Hematol</addtitle><subject>Acute Disease</subject><subject>Antilymphocyte Serum</subject><subject>Globulins</subject><subject>Graft vs Host Disease - drug therapy</subject><subject>Graft vs Host Disease - etiology</subject><subject>Graft vs Host Disease - prevention & control</subject><subject>Graft-versus-host reaction</subject><subject>Hematology</subject><subject>Hematopoietic Stem Cell Transplantation</subject><subject>Hematopoietic stem cells</subject><subject>Humans</subject><subject>Letter to the Editor</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Oncology</subject><subject>Skin diseases</subject><subject>Stem cell transplantation</subject><subject>Stem cells</subject><subject>Steroids</subject><subject>Thymocytes</subject><subject>Thymoglobulin</subject><subject>Transplantation</subject><issn>0925-5710</issn><issn>1865-3774</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNp9kk-P1CAYxonRuOPqF_BgSLysBxRKKcWb2ax_kkm8qNeGwtsOKy0j0DH9uH4TmZldTTx4IsDz_p4n8CD0nNHXjFL5JrGKtYLQihHKK14T_gBtWNsIwqWsH6INVZUgQjJ6gZ6kdEspk7SWj9EFF7RpWko36NcWcoaIc8B5B_jGuhziW_wN4op9-ElsSID1nF3erVMwawY8-tAv3s346nR2v32FXcIwDGCyOwAeQsSpkIOzJMIQtSngFWuzHBFRD5kcIKYlkV1IGVuXQBcrNx-CP7h5PMVJ34tNAY1LxmWi5NTehxFmcAbvYNI57IODXHbFa8IGvMc56jntfQmtswvzU_Ro0D7Bs7v1En19f_Pl-iPZfv7w6frdlhiuVCYNWAsAfVOBlkJB23Om6tZaziUX2vTccFBSCquBNYMRojeqV7Rpoacw1PwSXZ25-xh-LJByN7l0DKRnCEvqqqaqaqlUzYr05T_S27DEuaQrKs6FFLU6AquzysSQUnnDbh_dpOPaMdodC9CdC9CVAnSnAnS8DL24Qy_9BPbPyP2PFwE_C1K5mkeIf73_g_0NO4fDRw</recordid><startdate>20220301</startdate><enddate>20220301</enddate><creator>Yamada, Yuta</creator><creator>Konishi, Tatsuya</creator><creator>Nagata, Akihito</creator><creator>Toya, Takashi</creator><creator>Najima, Yuho</creator><creator>Kobayashi, Takeshi</creator><creator>Ohashi, Kazuteru</creator><creator>Doki, Noriko</creator><general>Springer Singapore</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7T5</scope><scope>7T7</scope><scope>7TM</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>C1K</scope><scope>CCPQU</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-8661-3179</orcidid></search><sort><creationdate>20220301</creationdate><title>Letter to the Editor: Very low-dose antithymocyte globulin (thymoglobulin) is effective for steroid-refractory acute graft-versus-host disease involving the skin or gut after allogeneic hematopoietic stem cell transplantation</title><author>Yamada, Yuta ; Konishi, Tatsuya ; Nagata, Akihito ; Toya, Takashi ; Najima, Yuho ; Kobayashi, Takeshi ; Ohashi, Kazuteru ; Doki, Noriko</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c399t-6eddeeeb62ea759e8b31948dd33735acb3c3e9775dae16fc55bc9b9068eb0ef43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Acute Disease</topic><topic>Antilymphocyte Serum</topic><topic>Globulins</topic><topic>Graft vs Host Disease - drug therapy</topic><topic>Graft vs Host Disease - etiology</topic><topic>Graft vs Host Disease - prevention & control</topic><topic>Graft-versus-host reaction</topic><topic>Hematology</topic><topic>Hematopoietic Stem Cell Transplantation</topic><topic>Hematopoietic stem cells</topic><topic>Humans</topic><topic>Letter to the Editor</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Oncology</topic><topic>Skin diseases</topic><topic>Stem cell transplantation</topic><topic>Stem cells</topic><topic>Steroids</topic><topic>Thymocytes</topic><topic>Thymoglobulin</topic><topic>Transplantation</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yamada, Yuta</creatorcontrib><creatorcontrib>Konishi, Tatsuya</creatorcontrib><creatorcontrib>Nagata, Akihito</creatorcontrib><creatorcontrib>Toya, Takashi</creatorcontrib><creatorcontrib>Najima, Yuho</creatorcontrib><creatorcontrib>Kobayashi, Takeshi</creatorcontrib><creatorcontrib>Ohashi, Kazuteru</creatorcontrib><creatorcontrib>Doki, Noriko</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database (ProQuest)</collection><collection>Immunology Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Nucleic Acids Abstracts</collection><collection>Health & Medical Collection (Proquest)</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Nursing & Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>International journal of hematology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yamada, Yuta</au><au>Konishi, Tatsuya</au><au>Nagata, Akihito</au><au>Toya, Takashi</au><au>Najima, Yuho</au><au>Kobayashi, Takeshi</au><au>Ohashi, Kazuteru</au><au>Doki, Noriko</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Letter to the Editor: Very low-dose antithymocyte globulin (thymoglobulin) is effective for steroid-refractory acute graft-versus-host disease involving the skin or gut after allogeneic hematopoietic stem cell transplantation</atitle><jtitle>International journal of hematology</jtitle><stitle>Int J Hematol</stitle><addtitle>Int J Hematol</addtitle><date>2022-03-01</date><risdate>2022</risdate><volume>115</volume><issue>3</issue><spage>449</spage><epage>451</epage><pages>449-451</pages><issn>0925-5710</issn><eissn>1865-3774</eissn><cop>Singapore</cop><pub>Springer Singapore</pub><pmid>35066800</pmid><doi>10.1007/s12185-021-03234-3</doi><tpages>3</tpages><orcidid>https://orcid.org/0000-0002-8661-3179</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0925-5710 |
ispartof | International journal of hematology, 2022-03, Vol.115 (3), p.449-451 |
issn | 0925-5710 1865-3774 |
language | eng |
recordid | cdi_proquest_miscellaneous_2622479941 |
source | MEDLINE; SpringerLink Journals |
subjects | Acute Disease Antilymphocyte Serum Globulins Graft vs Host Disease - drug therapy Graft vs Host Disease - etiology Graft vs Host Disease - prevention & control Graft-versus-host reaction Hematology Hematopoietic Stem Cell Transplantation Hematopoietic stem cells Humans Letter to the Editor Medicine Medicine & Public Health Oncology Skin diseases Stem cell transplantation Stem cells Steroids Thymocytes Thymoglobulin Transplantation |
title | Letter to the Editor: Very low-dose antithymocyte globulin (thymoglobulin) is effective for steroid-refractory acute graft-versus-host disease involving the skin or gut after allogeneic hematopoietic stem cell transplantation |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-12T07%3A36%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Letter%20to%20the%20Editor:%20Very%20low-dose%20antithymocyte%20globulin%20(thymoglobulin)%20is%20effective%20for%20steroid-refractory%20acute%20graft-versus-host%20disease%20involving%20the%20skin%20or%20gut%20after%20allogeneic%20hematopoietic%20stem%20cell%20transplantation&rft.jtitle=International%20journal%20of%20hematology&rft.au=Yamada,%20Yuta&rft.date=2022-03-01&rft.volume=115&rft.issue=3&rft.spage=449&rft.epage=451&rft.pages=449-451&rft.issn=0925-5710&rft.eissn=1865-3774&rft_id=info:doi/10.1007/s12185-021-03234-3&rft_dat=%3Cproquest_cross%3E2622479941%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2633575494&rft_id=info:pmid/35066800&rfr_iscdi=true |